Editorial
Gene methylation in liquid biopsy and risk of recurrence in lung cancer
Abstract
Belinsky and colleagues showed the potential utility for
predicting tumour recurrence of an 8-gene methylation
panel in plasma and sputum from resected Stage I non-small
cell lung cancer (NSCLC) patients (1).
predicting tumour recurrence of an 8-gene methylation
panel in plasma and sputum from resected Stage I non-small
cell lung cancer (NSCLC) patients (1).
